Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The closed system transfer devices market is experiencing significant growth driven by rising healthcare needs and safety concerns. As regulations tighten and cancer cases increase globally, the demand for safer drug handling solutions continues to accelerate. This overview explores the market size, key growth drivers, leading companies, and future trends shaping this vital healthcare segment.

Market Size and Projected Growth in the Closed System Transfer Devices Market

The closed system transfer devices market has seen rapid expansion in recent years. Valued at $1.18 billion in 2025, it is expected to grow to $1.35 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.2%. This growth during the historical period has been fueled by the increasing use of hazardous drugs in oncology, heightened awareness about occupational exposure risks, stringent safety guidelines for drug handling, the growth of hospital oncology services, and wider adoption of chemotherapy infusion therapies. Looking ahead, the market is forecasted to reach $2.18 billion by 2030, with a slightly moderated CAGR of 12.6%. Factors contributing to this projected surge include stricter regulatory enforcement related to hazardous drug handling, rising volumes of cancer treatments, enhanced emphasis on workplace safety compliance, global expansion of oncology centers, and increased investment in hospital pharmacy safety infrastructure. Important trends during this period feature broader adoption of closed drug handling systems in oncology, heightened focus on healthcare worker safety, growing preference for needleless closed transfer devices, wider use in hospital pharmacies, and greater standardization of hazardous drug protocols.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Key Factors Propelling Growth in the Closed System Transfer Devices Market

The rising incidence of cancer worldwide is a primary driver of the closed system transfer devices market. Cancer involves the uncontrolled growth and spread of abnormal cells that can invade tissues and metastasize through blood and lymphatic systems. Various factors, such as lifestyle habits, environmental exposures, and infectious agents, contribute to the growing number of cancer cases globally. Closed system transfer devices play an essential role in cancer treatment by protecting healthcare professionals and patients from exposure to hazardous chemotherapy drugs. Their use ensures safer environments in healthcare settings and supports improved treatment outcomes. For example, the World Health Organization (WHO) reported in February 2024 that cancer cases are expected to exceed 35 million by 2050, marking a 77% increase from the estimated 20 million cases projected for 2022. This sharp rise highlights the increasing global burden of cancer.

Additional Evidence of Cancer’s Impact on Market Demand

In the United States alone, the National Center for Biotechnology Information (NCBI) projected in January 2023 that there would be 1,958,310 new cancer cases diagnosed and 609,820 cancer-related deaths in 2023. These statistics underscore the substantial need for effective safety measures in cancer treatment, further boosting demand for closed system transfer devices. As cancer cases climb, the necessity for such protective technologies continues to grow, driving ongoing market expansion.

Access The Complete Closed System Transfer Devices Market Report:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Market Segments Dominating the Closed System Transfer Devices Industry

This market is segmented by multiple factors to provide detailed insights into product categories and end users:

1) By Type: Needleless Systems and Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, and Filtration technologies

3) By Closing Mechanism: Color-To-Color Alignment, Push-To-Turn, Click-To-Lock, and Luer-Lock systems

4) By End User: Hospitals and Clinics, Oncology Centers, and Other End Users

Further breakdown includes subsegments such as Needleless Systems comprising Closed Vial Systems, Closed Syringe Systems, and Transfer Device Adapters, while Membrane-To-Membrane Systems include Membrane-To-Membrane Transfer Devices and Filtered Membrane Transfer Devices.

Innovative Developments Defining the Future of the Closed System Transfer Devices Market

Leading players in the closed system transfer devices market are prioritizing innovation to enhance safety and usability while meeting stringent healthcare regulations. For instance, syringe units designed for full volume use—meaning they deliver the complete dose without requiring additional mixing—are gaining attention. In October 2023, Equashield, a US-based medical device firm, introduced the EQUASHIELD Syringe Unit, which received FDA clearance for full-volume application. This product prevents vapor escape and contamination of the plunger, offering a safer, more efficient, and cost-effective solution for compounding and administering hazardous drugs.

Key Players Shaping the Competitive Landscape in the Closed System Transfer Devices Market

Numerous prominent companies are actively competing in this market, including:

Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Aegis Medical Technologies, Epic Medical Pte Ltd., and Smiths Medical.

Regional Market Dynamics and Growth Opportunities in the Closed System Transfer Devices Market

In 2025, North America accounted for the largest share of the closed system transfer devices market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate over the forecast period. The market analysis covers key regions, including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive perspective on global market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model